Cargando…
Tuberculosis vaccine BCG: the magical effect of the old vaccine in the fight against the COVID-19 pandemic
Bacillus Calmette-Guérin (BCG) is a live attenuated M. bovis vaccine that was developed about 100 years ago by Albert Calmette and Camille Guérin. Many countries have been using the vaccine for decades against tuberculosis (TB). The World Health Organization (WHO) recommends a single dose of BCG for...
Autores principales: | Aspatwar, Ashok, Gong, Wenping, Wang, Shuyong, Wu, Xueqiong, Parkkila, Seppo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108189/ https://www.ncbi.nlm.nih.gov/pubmed/33960271 http://dx.doi.org/10.1080/08830185.2021.1922685 |
Ejemplares similares
-
Animal Models of Tuberculosis Vaccine Research: An Important Component in the Fight against Tuberculosis
por: Gong, Wenping, et al.
Publicado: (2020) -
Is the tuberculosis vaccine BCG an alternative weapon for developing countries to defeat COVID-19?
por: Gong, Wenping, et al.
Publicado: (2021) -
Editorial: Research advances of tuberculosis vaccine and its implication on COVID-19
por: Gong, Wenping, et al.
Publicado: (2023) -
The Impact of Transcriptomics on the Fight against Tuberculosis: Focus on Biomarkers, BCG Vaccination, and Immunotherapy
por: Zárate-Bladés, Carlos Rodrigo, et al.
Publicado: (2011) -
Exploring BCG vaccination as a novel approach to prevent recurrent herpes labialis
por: Gong, Wenping, et al.
Publicado: (2023)